Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
ACON

ACON - Aclarion, Inc. Stock Price, Fair Value and News

0.37USD+0.02 (+5.71%)Market Closed
Watchlist

Market Summary

USD0.37+0.02
Market Closed
5.71%

ACON Stock Price

View Fullscreen

ACON RSI Chart

ACON Valuation

Market Cap

3.3M

Price/Earnings (Trailing)

-0.71

Price/Sales (Trailing)

38.67

EV/EBITDA

-0.38

Price/Free Cashflow

-0.8

ACON Price/Sales (Trailing)

ACON Profitability

Operating Margin

12.51%

Return on Equity

-10.88%

Return on Assets

-297.47%

Free Cashflow Yield

-124.43%

ACON Fundamentals

ACON Revenue

Revenue (TTM)

84.1K

Rev. Growth (Yr)

4.63%

Rev. Growth (Qtr)

11.67%

ACON Earnings

Earnings (TTM)

-4.6M

Earnings Growth (Yr)

38.89%

Earnings Growth (Qtr)

31.86%

Breaking Down ACON Revenue

Last 7 days

-6.5%

Last 30 days

-44.9%

Last 90 days

517.9%

Trailing 12 Months

121.1%

How does ACON drawdown profile look like?

ACON Financial Health

Current Ratio

0.15

ACON Investor Care

Shares Dilution (1Y)

12.42%

Diluted EPS (TTM)

-0.09

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202376.9K83.3K84.1K0
202257.5K42.5K49.9K60.4K
202100060.3K

Tracking the Latest Insider Buys and Sells of Aclarion, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 28, 2023
thramann jeffrey john
sold
-1,000
1,000
-1.00
executive chairman
Feb 16, 2023
thramann jeffrey john
bought
1,000
1,000
1.00
executive chairman
Dec 29, 2022
lorbiecki john paul
bought
10,000
0.44634
22,404
chief financial officer
Dec 29, 2022
ness brent
bought
8,807
0.543297
16,211
chief executive officer
Dec 28, 2022
ness brent
bought
961
0.42
2,289
chief executive officer
Dec 02, 2022
sc capital 1 llc
sold
-
-
-1,091,890
-
Dec 02, 2022
neal david k
acquired
-
-
152,128
-
Apr 22, 2022
bond ryan
bought
56,000
2.8
20,000
chief strategy officer
Apr 21, 2022
wesemann william
bought
47,850
4.35
11,000
-
Apr 21, 2022
ness brent
bought
4,350
4.35
1,000
chief executive officer

1–10 of 11

Which funds bought or sold ACON recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 14, 2024
STATE STREET CORP
unchanged
-
-2,198
3,159
-%
Feb 14, 2024
CLEAR STREET LLC
reduced
-1.05
-2,000
2,000
-%
Feb 14, 2024
CAPTRUST FINANCIAL ADVISORS
unchanged
-
-3,685
2,195
-%
Feb 14, 2024
CAPTRUST FINANCIAL ADVISORS
added
10.94
-44,314
94,885
-%
Feb 14, 2024
TWO SIGMA SECURITIES, LLC
new
-
4,607
4,607
-%
Feb 14, 2024
Hudson Bay Capital Management LP
reduced
-50.00
-17,120
6,880
-%
Feb 14, 2024
CITADEL ADVISORS LLC
added
60.73
-304
5,530
-%
Feb 13, 2024
RENAISSANCE TECHNOLOGIES LLC
sold off
-100
-9,000
-
-%
Feb 13, 2024
ARMISTICE CAPITAL, LLC
unchanged
-
-19,250
22,000
-%
Feb 13, 2024
Tower Research Capital LLC (TRC)
reduced
-0.29
-1,687
2,657
-%

1–10 of 21

Are Funds Buying or Selling ACON?

Are funds buying ACON calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ACON
No. of Funds

Unveiling Aclarion, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jan 12, 2024
white lion capital llc
9.52%
80,000
SC 13G
Dec 29, 2023
white lion capital llc
0.0%
0
SC 13G/A
Oct 30, 2023
white lion capital llc
5.9%
487,500
SC 13G
Feb 03, 2023
nuvasive inc
14.4%
1,126,495
SC 13G

Recent SEC filings of Aclarion, Inc.

View All Filings
Date Filed Form Type Document
Feb 27, 2024
424B4
Prospectus Filed
Feb 27, 2024
8-K
Current Report
Feb 26, 2024
EFFECT
EFFECT
Feb 23, 2024
S-1/A
Initial Public Offering
Feb 21, 2024
8-K
Current Report
Feb 21, 2024
S-1/A
Initial Public Offering
Feb 06, 2024
S-1/A
Initial Public Offering
Feb 01, 2024
EFFECT
EFFECT
Feb 01, 2024
424B3
Prospectus Filed
Jan 31, 2024
S-1/A
Initial Public Offering

Aclarion, Inc. News

Latest updates
AmericanBankingNEWS4 hours ago
TradingView26 Feb 202402:28 pm
InvestorPlace26 Feb 202401:44 pm
InvestorsObserver14 Feb 202405:28 pm
InvestorPlace26 Jan 202408:00 am
Seeking Alpha22 Jan 202408:00 am
OrthoSpineNews02 Jan 202408:00 am

Aclarion, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q1
Revenue11.7%19.0017.0025.0023.0018.0011.009.0012.0011.0026.0012.00
Cost Of Revenue1.3%20.0019.0017.0017.0017.0014.0017.0016.0016.0020.0017.00
Gross Profit77.9%-493*-2.238.005.001.00-3.57-7.71-4.24-5.225.00-4.74
Operating Expenses-17.3%1,1621,4041,1899481,6342,2097651,064792632456
  S&GA Expenses-7.2%19320817714515912569.0012278.0065.0066.00
  R&D Expenses-20.7%198250204219291353205182275163168
Interest Expenses252.9%16647.001.002.002.001,34116316716883.0057.00
Income Taxes------------
Earnings Before Taxes31.9%-998-1,464---1,633-3,554-----
Net Income31.9%-998-1,464-1,183-944-1,633-3,554-936-1,014-2,952-465-517
Net Income Margin13.0%-54.57*-62.75*-95.15*-116.94*-143.05*-198.80*-93.39*-82.11*---
Free Cashflow-0.5%-952-947-1,013-1,135-1,098-2,406-309-832-829-492-246
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q4
Assets-23.0%1,5432,0041,8612,9154,1015,6211,8081,889
  Current Assets-54.3%3657986761,7012,8804,389565732
    Cash Equivalents-72.1%1716154581,4832,6663,80360.00453
  Net PPE-11.9%2.002.003.003.004.007.0011.0013.00
  Current Liabilities18.9%2,3711,9947366891,1681,381-7,619
Shareholder's Equity412578.4%42,18810.001,1252,2262,9334,24019,07719,054
  Retained Earnings-2.4%-43,016-42,018-40,553-39,370-38,425-36,792-33,109-31,886
  Additional Paid-In Capital0.4%42,18842,02841,67941,59641,35841,032-19,054
Shares Outstanding0.4%8,2318,2017,8627,8627,8224,374906906
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q1
Cashflow From Operations-0.5%-952-947-1,013-1,135-1,098-2,406-309-832-829-492-246
  Share Based Compensation0.5%13713783.00-51.8270270223.0084.0084.00-5.00
Cashflow From Investing78.7%-12.97-60.91-11.72-48.25-38.66-38.30-82.65-17.02-10.16-51.20-23.63
Cashflow From Financing-55.2%5221,165---6,187--50.002,571319

ACON Income Statement

2023-09-30
Condensed Statements of Operations (unaudited) - USD ($)
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue    
Revenue$ 19,065$ 18,222$ 61,607$ 37,924
Cost of revenue19,55817,02856,31248,009
Gross profit (loss)(493)1,1945,295(10,085)
Operating expenses:    
Sales and marketing192,896159,388577,969353,456
Research and development198,252290,966652,657848,995
General and administrative770,5341,184,1002,524,3083,406,572
Total operating expenses1,161,6821,634,4543,754,9344,609,023
(Loss) from operations(1,162,175)(1,633,260)(3,749,640)(4,619,108)
Other income (expense):    
Interest expense(166,332)(2,070)(214,850)(1,505,477)
Change in value of warrant and derivative liabilities330,2520318,4520
Other, net2452,29711602
Total other income (expense)164,165227103,613(1,504,875)
(Loss) before income taxes(998,010)(1,633,033)(3,646,027)(6,123,983)
Income tax provision0000
Net (loss)(998,010)(1,633,033)(3,646,027)(6,123,983)
Dividends accrued for preferred stockholders000(415,523)
Net (loss) allocable to common stockholders$ (998,010)$ (1,633,033)$ (3,646,027)$ (6,539,506)

ACON Balance Sheet

2023-09-30
Condensed Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash$ 161,450$ 1,472,806
Restricted cash10,00010,000
Accounts receivable21,18918,569
Prepaids and other current assets172,309199,701
Total current assets364,9481,701,076
Non-current assets:  
Property and equipment, net2,0633,346
Intangible assets, net1,176,2081,210,207
Total non-current assets1,178,2711,213,553
Total assets1,543,2192,914,629
Current liabilities:  
Accounts payable686,198462,202
Accrued and other liabilities379,119226,469
Note payable, net of discount727,5360
Warrant liability210,9100
Derivative liability367,4360
Total current liabilities2,371,199688,671
Stockholders' equity  
Common stock - $0.00001 par value, 200,000,000 authorized and 8,230,510 and 7,861,515 shares issued and outstanding (see Note 12)8279
Additional paid-in capital42,188,11741,596,032
Accumulated deficit(43,016,179)(39,370,153)
Total stockholders’ equity (deficit)(827,980)2,225,958
Total liabilities and stockholders’ equity (deficit)$ 1,543,219$ 2,914,629
ACON
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.
 CEO
 WEBSITEwww.aclarion.com
 EMPLOYEES7

Aclarion, Inc. Frequently Asked Questions


What is the ticker symbol for Aclarion, Inc.? What does ACON stand for in stocks?

ACON is the stock ticker symbol of Aclarion, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aclarion, Inc. (ACON)?

As of Wed Feb 28 2024, market cap of Aclarion, Inc. is 3.25 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ACON stock?

You can check ACON's fair value in chart for subscribers.

What is the fair value of ACON stock?

You can check ACON's fair value in chart for subscribers. The fair value of Aclarion, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Aclarion, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ACON so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Aclarion, Inc. a good stock to buy?

The fair value guage provides a quick view whether ACON is over valued or under valued. Whether Aclarion, Inc. is cheap or expensive depends on the assumptions which impact Aclarion, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACON.

What is Aclarion, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Feb 28 2024, ACON's PE ratio (Price to Earnings) is -0.71 and Price to Sales (PS) ratio is 38.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACON PE ratio will change depending on the future growth rate expectations of investors.